You've got plenty of data and plenty of questions. At Counterpoint Statistical Consulting we have the know-how and the experience to help.
Drawing on more than 35 years of experience in statistics, biostatistics, computing and technical writing, we are ideally suited to developing innovative yet rigorous solutions to your study design and analysis needs. We find the Bayesian analytic paradigm to be the most flexible and conceptually straightforward, but aren't too proud to use classical methods in settings where they are sensible. The interplay between these two complementary approaches is how Counterpoint got its name.
As of January 6, 2025, Counterpoint is now partnered with PhaseV Trials, Inc. (www.phasevtrials.com), a dynamic new software development and consulting firm catering to all aspects of pharmaceutical and medical device development, from preclinical and regulatory to post-market. The firm offers a software platform that incorporates all facets of Bayesian adaptive trial design (arm-dropping, early stopping for efficacy/futility, borrowing from historical data, etc.) that have become standard over the last few years. Even more remarkably, the platform also includes a wide array of machine learning (ML) tools for causal inference, as well as AI tools for protocol/SAP development and identification of relevant historical data (both from internet sources and the platform's own substantial "data lake") that are simply unmatched in the field. This enables us to tackle an enormously broad range of problems in statistics, data science, and AI/ML. Drop us a note on our "Contact Us" page above to let us know how we can help!
Drawing on more than 35 years of experience in statistics, biostatistics, computing and technical writing, we are ideally suited to developing innovative yet rigorous solutions to your study design and analysis needs. We find the Bayesian analytic paradigm to be the most flexible and conceptually straightforward, but aren't too proud to use classical methods in settings where they are sensible. The interplay between these two complementary approaches is how Counterpoint got its name.
As of January 6, 2025, Counterpoint is now partnered with PhaseV Trials, Inc. (www.phasevtrials.com), a dynamic new software development and consulting firm catering to all aspects of pharmaceutical and medical device development, from preclinical and regulatory to post-market. The firm offers a software platform that incorporates all facets of Bayesian adaptive trial design (arm-dropping, early stopping for efficacy/futility, borrowing from historical data, etc.) that have become standard over the last few years. Even more remarkably, the platform also includes a wide array of machine learning (ML) tools for causal inference, as well as AI tools for protocol/SAP development and identification of relevant historical data (both from internet sources and the platform's own substantial "data lake") that are simply unmatched in the field. This enables us to tackle an enormously broad range of problems in statistics, data science, and AI/ML. Drop us a note on our "Contact Us" page above to let us know how we can help!
